{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:42:35Z","timestamp":1788914555141,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21588"],"award-info":[{"award-number":["21588"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["2019\/24 PI: PT"],"award-info":[{"award-number":["2019\/24 PI: PT"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability, and telomere dysfunction is an important cause of acquired genomic alterations. Telomeric repeat-containing RNA (TERRA) transcripts are long non-coding RNAs involved in telomere stability through the interaction with shelterin complex. Dysregulation of TERRAs has been reported across several cancer types. We recently identified a small molecule,\n                      <jats:italic>hit<\/jats:italic>\n                      17, which stabilizes the secondary structure of TERRA. In this study, we investigated in vitro and in vivo anti-MM activities of\n                      <jats:italic>hit<\/jats:italic>\n                      17.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Anti-proliferative activity of\n                      <jats:italic>hit<\/jats:italic>\n                      17 was evaluated in different MM cell lines by cell proliferation assay, and the\u00a0apoptotic process was analyzed by flow cytometry. Gene and protein expressions were detected by RT-qPCR and western blotting, respectively. Microarray analysis was used to analyze\u00a0the transcriptome profile. The effect of\n                      <jats:italic>hit<\/jats:italic>\n                      17 on telomeric structure was evaluated by chromatin immunoprecipitation. Further evaluation in vivo was proceeded upon NCI-H929 and AMO-1 xenograft models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TERRA G4 stabilization induced in vitro dissociation of telomeric repeat\u2010binding factor 2 (TRF2) from telomeres leading to the activation of ATM-dependent DNA damage response, cell cycle arrest, proliferation block, and apoptotic death in MM cell lines. In addition, up-regulation of TERRA transcription was observed upon DNA damage and TRF2 loss. Transcriptome analysis followed by gene set enrichment analysis (GSEA)\u00a0confirmed the involvement of the above-mentioned processes and other pathways such as E2F, MYC, oxidative phosphorylation, and DNA repair genes as early events following\n                      <jats:italic>hit<\/jats:italic>\n                      17-induced TERRA stabilization. Moreover,\n                      <jats:italic>hit<\/jats:italic>\n                      17 exerted anti-tumor activity against MM xenograft models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our findings provide evidence that targeting TERRA by\n                      <jats:italic>hit<\/jats:italic>\n                      17 could represent a promising strategy for a novel therapeutic approach to MM.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-023-02633-0","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:02:38Z","timestamp":1679868158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma"],"prefix":"10.1186","volume":"42","author":[{"given":"Francesca","family":"Scionti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Juli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Poler\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Grillone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Caracciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Riillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Altomare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ascrizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilio","family":"Caparello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariamena","family":"Arbitrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara N.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Artese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alcaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierosandro","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-2706","authenticated-orcid":false,"given":"Maria Teresa","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"2633_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.trecan.2020.05.006","volume":"6","author":"DA Alagpulinsa","year":"2020","unstructured":"Alagpulinsa DA, Szalat RE, Poznansky MC, Shmookler Reis RJ. Genomic instability in multiple myeloma. Trends Cancer. 2020;6:858\u201373.","journal-title":"Trends Cancer"},{"key":"2633_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41375-018-0206-x","volume":"33","author":"AK Dutta","year":"2019","unstructured":"Dutta AK, Fink JL, Grady JP, Morgan GJ, Mullighan CG, To LB, Hewett DR, Zannettino ACW. Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability. Leukemia. 2019;33:457\u201368.","journal-title":"Leukemia"},{"key":"2633_CR3","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/labinvest.3700673","volume":"87","author":"Y Deng","year":"2007","unstructured":"Deng Y, Chang S. Role of telomeres and telomerase in genomic instability, senescence and cancer. Lab Invest. 2007;87:1071\u20136.","journal-title":"Lab Invest"},{"key":"2633_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-genet-032918-021921","volume":"52","author":"T de Lange","year":"2018","unstructured":"de Lange T. Shelterin-mediated telomere protection. Annu Rev Genet. 2018;52:223\u201347.","journal-title":"Annu Rev Genet"},{"key":"2633_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fgene.2015.00143","volume":"6","author":"E Cusanelli","year":"2015","unstructured":"Cusanelli E, Chartrand P. Telomeric repeat-containing RNA TERRA: a noncoding RNA connecting telomere biology to genome integrity. Front Genet. 2015;6:143.","journal-title":"Front Genet"},{"key":"2633_CR6","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1021\/ja100345z","volume":"132","author":"GW Collie","year":"2010","unstructured":"Collie GW, Parkinson GN, Neidle S, Rosu F, De Pauw E, Gabelica V. Electrospray mass spectrometry of telomeric RNA (TERRA) reveals the formation of stable multimeric G-quadruplex structures. J Am Chem Soc. 2010;132:9328\u201334.","journal-title":"J Am Chem Soc"},{"key":"2633_CR7","doi-asserted-by":"publisher","first-page":"11974","DOI":"10.1021\/ja305734x","volume":"134","author":"G Biffi","year":"2012","unstructured":"Biffi G, Tannahill D, Balasubramanian S. An intramolecular G-quadruplex structure is required for binding of telomeric repeat-containing RNA to the telomeric protein TRF2. J Am Chem Soc. 2012;134:11974\u20136.","journal-title":"J Am Chem Soc"},{"key":"2633_CR8","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1038\/s41598-021-82406-x","volume":"11","author":"Y Mei","year":"2021","unstructured":"Mei Y, Deng Z, Vladimirova O, Gulve N, Johnson FB, Drosopoulos WC, Schildkraut CL, Lieberman PM. TERRA G-quadruplex RNA interaction with TRF2 GAR domain is required for telomere integrity. Sci Rep. 2021;11:3509.","journal-title":"Sci Rep"},{"key":"2633_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cell.2013.09.048","volume":"155","author":"Y Doksani","year":"2013","unstructured":"Doksani Y, Wu JY, de Lange T, Zhuang X. Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation. Cell. 2013;155:345\u201356.","journal-title":"Cell"},{"key":"2633_CR10","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1093\/nar\/gkq296","volume":"38","author":"S Redon","year":"2010","unstructured":"Redon S, Reichenbach P, Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res. 2010;38:5797\u2013806.","journal-title":"Nucleic Acids Res"},{"key":"2633_CR11","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/s41467-018-03916-3","volume":"9","author":"JJ Montero","year":"2018","unstructured":"Montero JJ, Lopez-Silanes I, Megias D. M FF, Castells-Garcia A, Blasco MA: TERRA recruitment of polycomb to telomeres is essential for histone trymethylation marks at telomeric heterochromatin. Nat Commun. 2018;9:1548.","journal-title":"Nat Commun"},{"key":"2633_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb1685","volume":"10","author":"S Schoeftner","year":"2008","unstructured":"Schoeftner S, Blasco MA. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol. 2008;10:228\u201336.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2633_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1593\/tlo.11202","volume":"5","author":"S Sampl","year":"2012","unstructured":"Sampl S, Pramhas S, Stern C, Preusser M, Marosi C, Holzmann K. Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade. Transl Oncol. 2012;5(1):56\u201365.","journal-title":"Transl Oncol"},{"issue":"1","key":"2633_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/ijms19010274","volume":"19","author":"V Vitelli","year":"2018","unstructured":"Vitelli V, Falvo P, Nergadze SG, et al. Telomeric repeat-containing RNAs (TERRA) decrease in squamous cell carcinoma of the head and neck is associated with worsened clinical outcome. Int J Mol Sci. 2018;19(1):274.\u00a0","journal-title":"Int J Mol Sci"},{"key":"2633_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13046-020-01622-x","volume":"39","author":"K Grillone","year":"2020","unstructured":"Grillone K, Riillo C, Scionti F, Rocca R, Tradigo G, Guzzi PH, Alcaro S, Di Martino MT, Tagliaferri P, Tassone P. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic \u201cdark matter.\u201d J Exp Clin Cancer Res. 2020;39:117.","journal-title":"J Exp Clin Cancer Res"},{"key":"2633_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-021-01328-4","volume":"20","author":"N Kosiol","year":"2021","unstructured":"Kosiol N, Juranek S, Brossart P, Heine A, Paeschke K. G-quadruplexes: a promising target for cancer therapy. Mol Cancer. 2021;20:40.","journal-title":"Mol Cancer"},{"key":"2633_CR17","doi-asserted-by":"publisher","first-page":"111891","DOI":"10.1016\/j.ejmech.2019.111891","volume":"186","author":"MH Hu","year":"2020","unstructured":"Hu MH, Lin XT, Liu B, Tan JH. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere. Eur J Med Chem. 2020;186:111891.","journal-title":"Eur J Med Chem"},{"key":"2633_CR18","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1021\/acs.jmedchem.7b01615","volume":"61","author":"T Che","year":"2018","unstructured":"Che T, Chen SB, Tu JL, Wang B, Wang YQ, Zhang Y, Wang J, Wang ZQ, Zhang ZP, Ou TM, et al. Discovery of novel schizocommunin derivatives as telomeric G-quadruplex ligands that trigger telomere dysfunction and the Deoxyribonucleic Acid (DNA) damage response. J Med Chem. 2018;61:3436\u201353.","journal-title":"J Med Chem"},{"key":"2633_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13046-020-01582-2","volume":"39","author":"SL George","year":"2020","unstructured":"George SL, Parmar V, Lorenzi F, Marshall LV, Jamin Y, Poon E, Angelini P, Chesler L. Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma. J Exp Clin Cancer Res. 2020;39:78.","journal-title":"J Exp Clin Cancer Res"},{"key":"2633_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.bbagen.2016.12.023","volume":"1861","author":"R Rocca","year":"2017","unstructured":"Rocca R, Moraca F, Costa G, Nadai M, Scalabrin M, Talarico C, Distinto S, Maccioni E, Ortuso F, Artese A, et al. Identification of G-quadruplex DNA\/RNA binders: structure-based virtual screening and biophysical characterization. Biochim Biophys Acta Gen Subj. 2017;1861:1329\u201340.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2633_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/ph15050548","volume":"15","author":"R Rocca","year":"2022","unstructured":"Rocca R, Scionti F, Nadai M, Moraca F, Maruca A, Costa G, Catalano R, Juli G, Martino MTD, Ortuso F, et al. Chromene derivatives as selective TERRA G-quadruplex RNA binders with antiproliferative properties. Pharmaceuticals. 2022;15:548.\u00a0","journal-title":"Pharmaceuticals"},{"key":"2633_CR22","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"2633_CR23","doi-asserted-by":"publisher","first-page":"8632","DOI":"10.1021\/acs.analchem.7b01282","volume":"89","author":"M Scalabrin","year":"2017","unstructured":"Scalabrin M, Palumbo M, Richter SN. Highly improved electrospray ionization-mass spectrometry detection of G-quadruplex-folded oligonucleotides and their complexes with small molecules. Anal Chem. 2017;89(17):8632\u20137.","journal-title":"Anal Chem"},{"issue":"2","key":"2633_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tig.2018.11.001","volume":"35","author":"AK Mukherjee","year":"2019","unstructured":"Mukherjee AK, Sharma S, Chowdhury S. Non-duplex G-quadruplex structures emerge as mediators of epigenetic modifications. Trends Genet. 2019;35(2):129\u201344.","journal-title":"Trends Genet"},{"key":"2633_CR25","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1158\/1078-0432.CCR-12-1708","volume":"18","author":"MT Di Martino","year":"2012","unstructured":"Di Martino MT, Leone E, Amodio N, Foresta U, Lionetti M, Pitari MR, Cantafio ME, Gulla A, Conforti F, Morelli E, et al. Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence. Clin Cancer Res. 2012;18:6260\u201370.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2633_CR26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2141.2008.07387.x","volume":"143","author":"P Neri","year":"2008","unstructured":"Neri P, Tagliaferri P, Di Martino MT, Calimeri T, Amodio N, Bulotta A, Ventura M, Eramo PO, Viscomi C, Arbitrio M, Rossi M, Caraglia M, Munshi NC, Anderson KC, Tassone P. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor. Br J Haematol. 2008;143(4):520\u201331.","journal-title":"Br J Haematol"},{"key":"2633_CR27","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1016\/j.bbagen.2017.09.015","volume":"1861","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Zeng D, Cao J, Wang M, Shu B, Kuang G, Ou TM, Tan JH, Gu LQ, Huang ZS, Li D. Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2. Biochim Biophys Acta Gen Subj. 2017;1861:3246\u201356.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2633_CR28","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1038\/ncomms6379","volume":"5","author":"A Porro","year":"2014","unstructured":"Porro A, Feuerhahn S, Delafontaine J, Riethman H, Rougemont J, Lingner J. Functional characterization of the TERRA transcriptome at damaged telomeres. Nat Commun. 2014;5:5379.","journal-title":"Nat Commun"},{"key":"2633_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13046-019-1030-5","volume":"38","author":"S Cacchione","year":"2019","unstructured":"Cacchione S, Biroccio A, Rizzo A. Emerging roles of telomeric chromatin alterations in cancer. J Exp Clin Cancer Res. 2019;38:21.","journal-title":"J Exp Clin Cancer Res"},{"key":"2633_CR30","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0960-9822(03)00542-6","volume":"13","author":"H Takai","year":"2003","unstructured":"Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol. 2003;13:1549\u201356.","journal-title":"Curr Biol"},{"key":"2633_CR31","doi-asserted-by":"publisher","first-page":"E240","DOI":"10.1371\/journal.pbio.0020240","volume":"2","author":"J Karlseder","year":"2004","unstructured":"Karlseder J, Hoke K, Mirzoeva OK, Bakkenist C, Kastan MB, Petrini JH, de Lange T. The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response. PLoS Biol. 2004;2:E240.","journal-title":"PLoS Biol"},{"key":"2633_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nsmb.3092","volume":"22","author":"N Arnoult","year":"2015","unstructured":"Arnoult N, Karlseder J. Complex interactions between the DNA-damage response and mammalian telomeres. Nat Struct Mol Biol. 2015;22:859\u201366.","journal-title":"Nat Struct Mol Biol"},{"key":"2633_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability\u2013an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2633_CR34","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1038\/s41375-020-0921-y","volume":"34","author":"CJ Neuse","year":"2020","unstructured":"Neuse CJ, Lomas OC, Schliemann C, Shen YJ, Manier S, Bustoros M, Ghobrial IM. Genome instability in multiple myeloma. Leukemia. 2020;34:2887\u201397.","journal-title":"Leukemia"},{"key":"2633_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41375-018-0238-2","volume":"33","author":"D Caracciolo","year":"2019","unstructured":"Caracciolo D, Di Martino MT, Amodio N, Morelli E, Montesano M, Botta C, Scionti F, Talarico D, Altomare E, Gallo Cantafio ME, et al. miR-22 suppresses DNA ligase III addiction in multiple myeloma. Leukemia. 2019;33:487\u201398.","journal-title":"Leukemia"},{"key":"2633_CR36","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/cancers13061392","volume":"13","author":"D Caracciolo","year":"2021","unstructured":"Caracciolo D, Riillo C, Di Martino MT, Tagliaferri P, Tassone P. Alternative non-homologous end-joining: error-prone DNA repair as cancer\u2019s Achilles\u2019 heel. Cancers (Basel). 2021;13:1392.","journal-title":"Cancers (Basel)"},{"key":"2633_CR37","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/cancers13081969","volume":"13","author":"A Rangel-Pozzo","year":"2021","unstructured":"Rangel-Pozzo A, Yu PLI, La LS, Asbaghi Y, Sisdelli L, Tammur P, Tamm A, Punab M, Klewes L, Louis S, et al. Telomere architecture correlates with aggressiveness in multiple myeloma. Cancers (Basel). 2021;13:1969.","journal-title":"Cancers (Basel)"},{"key":"2633_CR38","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/cancers12071901","volume":"12","author":"SG Fernandes","year":"2020","unstructured":"Fernandes SG, Dsouza R, Pandya G, Kirtonia A, Tergaonkar V, Lee SY, Garg M, Khattar E. Role of telomeres and telomeric proteins in human malignancies and their therapeutic potential. Cancers (Basel). 2020;12:1901.","journal-title":"Cancers (Basel)"},{"key":"2633_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13046-018-0767-6","volume":"37","author":"MF Santolla","year":"2018","unstructured":"Santolla MF, Lappano R, Cirillo F, Rigiracciolo DC, Sebastiani A, Abonante S, Tassone P, Tagliaferri P, Di Martino MT, Maggiolini M, Vivacqua A. miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20\/c-Rel\/CTGF signaling. J Exp Clin Cancer Res. 2018;37:94.","journal-title":"J Exp Clin Cancer Res"},{"key":"2633_CR40","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.1038\/s41598-018-29737-4","volume":"8","author":"W Qin","year":"2018","unstructured":"Qin W, Kang P, Xu Y, Leng K, Li Z, Huang L, Gao J, Cui Y, Zhong X. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma. Sci Rep. 2018;8:12176.","journal-title":"Sci Rep"},{"issue":"1","key":"2633_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/1389450117666160606104208","volume":"18","author":"G Misso","year":"2017","unstructured":"Misso G, Zarone MR, Grimaldi A, Di Martino MT, Lombardi A, Kawasaki H, Stiuso P, Tassone P, Tagliaferri P, Caraglia M. Non coding RNAs: A New avenue for the self-tailoring of blood cancer treatment. Curr Drug Targets. 2017;18(1):35\u201355.","journal-title":"Curr Drug Targets"},{"key":"2633_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.625019","volume":"12","author":"M Lu","year":"2021","unstructured":"Lu M, Wu Y, Gao W, Tian Y, Wang G, Liu A, Chen W. Novel non-coding RNA analysis in multiple myeloma identified through high-throughput sequencing. Front Genet. 2021;12: 625019.","journal-title":"Front Genet"},{"key":"2633_CR43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.omtn.2022.02.005","volume":"27","author":"MT Di Martino","year":"2022","unstructured":"Di Martino MT, Arbitrio M, Caracciolo D, Cordua A, Cuomo O, Grillone K, Riillo C, Carid\u00e0 G, Scionti F, Labanca C, Romeo C, Siciliano MA, D\u2019Apolito M, Napoli C, Montesano M, Farenza V, Uppolo V, Tafuni M, Falcone F, D\u2019Aquino G, Calandruccio ND, Luciano F, Pensabene L, Tagliaferri P, Tassone P. miR-221\/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: a systematic review. Mol Ther Nucleic Acids. 2022;27:1191\u2013224.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"10","key":"2633_CR44","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2174\/13894501113149990186","volume":"14","author":"M Rossi","year":"2013","unstructured":"Rossi M, Amodio N, Di Martino MT, Caracciolo D, Tagliaferri P, Tassone P. From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario. Curr Drug Targets. 2013;14(10):1144\u20139.","journal-title":"Curr Drug Targets."},{"issue":"11","key":"2633_CR45","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.3390\/ijms23116183","volume":"23","author":"M Manganelli","year":"2022","unstructured":"Manganelli M, Grossi I, Corsi J, D\u2019Agostino VG, Jurikova K, Cusanelli E, Molfino S, Portolani N, Salvi A, De Petro G. Expression of cellular and extracellular TERRA, TERC and TERT in hepatocellular carcinoma. Int J Mol Sci. 2022;23(11):6183.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2633_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12890-017-0516-1","volume":"17","author":"Y Gao","year":"2017","unstructured":"Gao Y, Zhang J, Liu Y, Zhang S, Wang Y, Liu B, Liu H, Li R, Lv C, Song X. Regulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis. BMC Pulm Med. 2017;17(1):163.","journal-title":"BMC Pulm Med"},{"key":"2633_CR47","doi-asserted-by":"publisher","unstructured":"Caracciolo D, Scionti F, Juli G, Altomare E, Golino G, Todoerti K, et al. Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma. Haematologica. 2021;106(1):185\u201395. https:\/\/doi.org\/10.3324\/haematol.2019.240713.","DOI":"10.3324\/haematol.2019.240713"},{"key":"2633_CR48","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s41375-018-0017-0","volume":"32","author":"C Pawlyn","year":"2018","unstructured":"Pawlyn C, Loehr A, Ashby C, Tytarenko R, Deshpande S, Sun J, et al. Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition? Leukemia. 2018;32:1561\u20136.","journal-title":"Leukemia"},{"key":"2633_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fonc.2014.00289","volume":"4","author":"DA Alagpulinsa","year":"2014","unstructured":"Alagpulinsa DA. Ayyadevara S and Shmookler Reis RJ (2014) A small-molecule inhibitor of RAD51 reduces homologous recombination and sensitizes multiple myeloma cells to doxorubicin. Front Oncol. 2014;4:289.\u00a0","journal-title":"Front Oncol"},{"issue":"6","key":"2633_CR50","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/15384047.2015.1040951","volume":"16","author":"DA Alagpulinsa","year":"2015","unstructured":"Alagpulinsa DA, Yaccoby S, Ayyadevara S, Shmookler RJ. A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment. Cancer Biol Ther. 2015;16(6):976\u201386.\u00a0","journal-title":"Cancer Biol Ther"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02633-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02633-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T12:22:11Z","timestamp":1702124531000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02633-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2633"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02633-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1627112\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"5 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All in vivo experiments were approved by the Institutional Ethical Committee of the Magna Graecia University and all the procedures were performed according to the Institutional Animal Care-approved protocols and guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}